Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0000886744-11-000064
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-05-24 22:39:20
Reporting Period:
2011-05-20
Filing Date:
2011-05-24
Accepted Time:
2011-05-24 21:39:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
886744 Geron Corp GERN Pharmaceutical Preparations (2834) 752287752
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1187035 Jane Lebkowski C/o Geron Corporation
230 Constitution Drive
Menlo Park CA 94025
Svp, Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-05-20 25,000 $0.00 521,891 No 4 A Direct
Common Stock Acquisiton 2011-05-20 64,500 $0.00 586,391 No 4 A Direct
Common Stock Acquisiton 2011-05-20 5,000 $0.00 591,391 No 4 A Direct
Common Stock Acquisiton 2011-05-20 5,000 $0.00 596,391 No 4 A Direct
Common Stock Disposition 2011-05-24 2,975 $4.47 593,416 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 A Direct
No 4 A Direct
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Acquisiton 2011-05-20 50,000 $0.00 50,000 $4.65
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
50,000 2021-05-20 No 4 A Direct
Footnotes
  1. The shares of restricted stock will remain subject to a repurchase right of Geron over four years, during such time the repurchase right will lapse with respect to 25% of such shares on each anniversary date of May 28, 2011. The lapse of Geron's repurchase right is conditioned on the employee continuing to provide services to Geron through each vesting date.
  2. The shares of restricted stock will remain subject to a repurchase right of Geron over two years, during which time the repurchase right will lapse with respect to 50% of such shares on each anniversary date of May 28, 2011. The lapse of Geron's repurchase right is conditioned on the employee continuing to provide services to Geron through each vesting date.
  3. The shares of restricted stock will remain subject to a reacquisition right of Geron over 19 months until the achievement of certain performance milestone critiera in connection with the Company's GRN1005 program.
  4. The shares of restricted stock will remain subject to a reacquisition right of Geron over three years until the achievement of certain performance milestone critiera in connection with the Company's GRN1005 program.
  5. This option is exercisable in a series of 48 consecutive equal monthly installments commencing May 20, 2011, provided the optionee continues to provide services to the Company.
  6. Shares sold for payment of payroll tax withholdings in connection with vesting of restricted stock award.